Nine Point Two Capital LLC Novavax Inc Transaction History

Nine Point Two Capital LLC

  • $252 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$6.81 - $9.74 $46,641 - $66,709
-6,849 Reduced 19.39%
28,477 $206,000
Q2 2023

Aug 14, 2023
SELL
$6.67 - $9.52 $57,515 - $82,090
-8,623 Reduced 19.62%
35,326 $262,000
Q1 2023

May 15, 2023
BUY
$5.76 - $12.48 $253,146 - $548,483
43,949 New
43,949 $304,000

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Nine Point Two Capital LLC Portfolio

Follow Nine Point Two Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Point Two Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email